GSK's Witty Knighted
This article was originally published in Scrip
Executive Summary
Andrew Witty, chief executive UK pharma giant GlaxoSmithKline, has been awarded a Knighthood in the UK's New Year Honours list, in recognition of his work for the company and the country's pharmaceutical industry. Also honoured in the New Year list was Richard Barker, former director general of the Association of the British Pharmaceutical Industry (ABPI), who was made an Officer of the Order of the British Empire (OBE) for his services to the pharmaceutical industry.
You may also be interested in...
UK Reimbursement Decisions Focus Mostly On Cancer
The UK's main reimbursement bodies made a series of decisions this week that were broadly favorable and largely focused on oncology medicines.
Deal Watch: Valeant Sells Off iNova To Finance Debt-Reduction Efforts
While troubled Valeant was divesting iNova to private equity investors, Novartis announced a pair of oncology-focused deals, out-licensing a brain cancer drug to Midatech and partnering with IBM Watson Health to optimize breast cancer treatment.
Pfizer/Astellas Amend Trial To Position Xtandi In Early Prostate Cancer
Astellas and Pfizer have amended the PROSPER trial protocol in a bid to position Xtandi ahead of Zytiga in the early stage prostate cancer market.